MAAT INDEX

CLAIM #50275 · PM (PM) · 2025Q1 earnings call · Apr 23, 2025 · due Dec 31, 2025

As announced in this morning's press release, we are raising our 2025 adjusted diluted EPS forecast to $7.36 to $7.49.

Emmanuel Babeau · CFO

CANNOT_DETERMINE
resolved by a revision, graded at the moved level · official band 5 percent
Committed
raising our 2025 adjusted diluted EPS forecast to $7.36 to $7.49
Reported
we expect adjusted diluted EPS growth of plus 13% to plus 15%

In context

tigate potential supply chain challenges. While the situation is volatile, we do not currently anticipate a material impact on our business from recently introduced or discussed tariffs. We expect a continuation of strong momentum from our smoke-free business, including the benefits of further multi-category deployment. As I explained, we are raising our forecast for U.S. in shipment to 800 to 840 million cans. This further supports our forecast of plus 12% to plus 14% SFP shipment growth, which incorporates unchanged strong growth assumptions for IQOS. We also continue to expect total semi-organic net revenue growth in the range of plus 6% to plus 8%, organic operating income growth of plus 10.5% to plus 12.5%, and currency-neutral adjusted diluted EPS growth of plus 10.5% to plus 12.5%. As announced in this morning's press release, we are raising our 2025 adjusted diluted EPS forecast to $7.36 to $7.49. This now reflects plus 12% to plus 14% growth in dollar terms, and includes a favorable estimated currency impact of $0.10 at the value exchange rate. This reflects recent strength in the Euro, Japanese yen, and Russian rubles, vastly offset by a stronger Swiss Franc. For Q2, we assume HTU shipment volume of 37.5 to 38.5 billion, with another strong quarter of HTU adjusted IMS growth of around plus 10%. For U.S. ZYN, we expect shipment to be at a similar level to Q1, as trade restocking continues and offtake gradually accelerates. We forecast adjusted diluted EPS of $1.80 to $1.85, including a favorable currency variance of $0.06 at prevailing rates. We expect a strong H1 overall, with organic net revenue growth around the IM of our target range for the full year, and organic OI growth sl

Verify independently

SEC filings for PM · Claim quote is verbatim from the 2025Q1 earnings call.